Gene Query: IGHG4

Dataset Description Geneva Score
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 221.32
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 104.25
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 104.25
Anti-inflammatory effect of indoleacrylic acid (IA) 98.92
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 83.86
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 75.1
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 72.07
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 65.79
RNA-sequencing of formalin fixed human primary melanoma tissue 63.38
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 63.38
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 63.38
Primate transcript and protein expression levels evolve under compensatory selection pressures 62.23
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 48.05
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 47.1
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 44.09
Gene expression profiling of papillary thyroid cancer from central and invasive regions 42.12
Fibroblasts in cholesteatoma activate osteoclasts. 37.4
Transcriptome analysis of eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps reveals distinct lncRNA expression profiles 37.25
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 35.7
Transcriptome analysis reveals differential splicing events in IPF lung tissue 30.05
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 29.93
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 29.93
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 29.62
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 29.42
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 29.27
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 28.12
Be1 and Be2 B cells are transcriptionally distinct 27.01
The evolution of N6-methyladenosine in primates 25.37
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 24.44
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 24.07
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 24.07
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 22.83
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 20.97
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 20.97
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 20.93
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 20.69
Non-IG Aberrations of FOXP1 in B-Cell Malignancies Lead to an Aberrant Expression of N-Truncated Isoforms of FOXP1 19.93
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 19.91
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 18.54
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 18.39
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 18.22
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 17.11
Specific molecular signatures underlie response to decitabine in CMML 16.84
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 16.84
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 16.72
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 16.6
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 16.28
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 16.09
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 15.42
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 15.39
An acquired vulnerability of drug resistant melanoma with therapeutic potential 15.39
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 14.52
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 14.1
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 14.07
ML29755 RNA-seq data 13.96
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 13.58
Molecular analysis of renal cell carcinoma with unclassfied histology 13.5
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 13.5
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 13.43
Characterization of human ILC2 subsets 13.4
Gene Expression Profiling of Cutaneous CD30+ Lymphoproliferative Disorders by RNA-seq 13.22
RNAseq analysis of ruxolitinib treated breast cancers 13.18
Bone marrow derived human B cells [normal proB] 13.03
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 12.89
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 12.89
RNA Sequencing of three pairs of gastric cancer 12.84
CD86 regulates a pro-survival signal in myeloma cells 12.7
Human optic chiasm from healthy controls and multiple sclerosis patients 12.4
Multiple sclerosis and EAE 12.4
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 11.79
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 11.06
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 11.03
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 10.89
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 10.79
The expression profiles of GBC liver metastasis 10.58
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 10.56
quanTIseq: quantifying immune contexture of human tumors 10.15
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 10.12
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 9.94
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 9.91
Landscape of H3K4me3 in human CD19 cells 9.81
Evaluating pre-clinical models for studying NASH driven HCC. 9.76
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 9.56
Non-coding regions are the main source of tumor-specific antigens 9.23
Non-coding regions are the main source of tumor-specific antigens [human] 9.23
Gene expression profiling in metabolically heterogeneous human lung tumors 8.99
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 8.87
Dysregulated immune system networks in war veterans with PTSD 8.85
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 8.84
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 8.7
A novel target of EZH1/2 for treatment of mantle cell lymphoma 8.43
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 8.41
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 8.18
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 8.18
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 8.13
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 8.1
BACH2 in human plasma cell fate decision 8.07
The gene expression profiles of gallbladder cancer 7.69
Polarized B -cell functions 7.68
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 7.5
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 7.39
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 7.38
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 7.31
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 7.31
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 6.91
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 6.45
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 6.37
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 6.37
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 6.16
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 6.14
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.91
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 5.9
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 5.81
Gene expression profile of multiple myeloma cell lines treated with CB-5083 5.78
Identification of miRNA-mRNA regulatory network for Human Atrial Aging [mRNA] 5.7
Identification of miRNA-mRNA regulatory network for Human Atrial Aging 5.7
RNA-seq melanoma 5.69
Ro60-knockout cells 5.63
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.6
Hepatosplenic T cell lymphoma 5.6
RNA-Seq from human ILC transitional populations 5.57
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 5.57
circRNA profile in hypopharyngeal cancer 5.42
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 5.4
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 5.4
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 5.35
Single cell transcriptome of peritoneal cells 5.31
RNA-Seq analysis of human colorectal cancer with liver metastasis 5.31
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 5.31
mRNA-sequencing of breast cancer subtypes and normal tissue 5.3
Hepatic transcriptome of pediatric hepatoblastoma. 5.22
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 5.2
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 5.2
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 5.2
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism: Liver RNA profiles of lean non-diabetic, obese non-diabetic as well as obese diabetic humans. 5.19
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism. 5.19
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 5.19
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 5.16
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 4.98
RNA-seq of stable and unstable section of human atherosclerotic plaques 4.89
RNA expression profiles comparing primary and omental ovarian carcinoma samples 4.71
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 4.65
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 4.61
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 4.61
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 4.53
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 4.33
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 4.23
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 4.21
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 4.21
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 4.07
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 4.06
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 4.06
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 4.05
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 4.05
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 4.03
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 3.89
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 3.88
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 3.88
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.87
Transcriptional profiling of microglia; current state of the art and future perspectives 3.85
Transcriptional profiles of normal human mature B cells 3.84
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.8
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 3.73
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.71
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.66
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.64
Total RNA-Seq data from leukemic patients with complex structural variants 3.63
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.62
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 3.22
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 3.19
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 3.15
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 3.1
The role of m6A/m-RNA methylation in stress response regulation 3.1
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 3.1
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 3.08
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 3.03
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 3.03
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 3.02
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 2.99
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 2.97
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 2.96
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 2.95
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.94
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 2.8
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 2.78
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.66
Expression analysis of the TAF1 syndrome 2.66
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 2.66
Expression patterns in chronic thromboembolic pulmonary hypertension 2.62
RNA-sequencing of human tendon after injury 2.55
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 2.52
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 2.5
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 2.46
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 2.45
circNFIB suppresses lymphatic metastasis of pancreatic cancer 2.44
Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma 2.42
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 2.4
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 2.37
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 2.37
The DNA methylation landscape of human melanoma 2.35
The DNA methylation landscape of human melanoma [RNA-Seq] 2.35
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.27
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 2.25
Human T-cell lymphoblastic lymphoma samples and control thymuses 2.25
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 2.23
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 2.21
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.2
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 2.17
Landscape and variation of RNA secondary structure across the human transcriptome 2.15
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.11
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 1.97
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.93
CD74 role in transcription regulation 1.84
CD74 role in transcription regulation [RNA-seq] 1.84
Transcriptional profile in human S. haematobium infection 1.8
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.76
The Genetic Landscape of Diamond-Blackfan Anemia 1.75
A practical evaluation of alignment algorithms for RNA variant calling analysis 1.73
MHC Transcriptomic landscape at haplotype-specific resolution 1.73
Gene expression analysis of human adenomas. 1.72
Measure transcript integrity using RNA-seq data 1.71
CircRNAome diversity in human mature B-cells, T-cells and monocytes 1.7
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 1.7
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 1.67
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 1.62
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 1.61
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.59
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.59
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.53
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 1.46
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 1.46
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 1.38
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.38
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.37
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.37
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.32
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 1.28
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.27
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 1.25
Frailty in middle age is associated with race-specific changes to the transcriptome. 1.25
Illumina HiSeq Sequencing on Breast cancer PDX samples 1.25
A robust qualitative transcriptional signature for the early diagnosis of gastric cancer 1.24
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours 1.23
Compared performance of Affymetrix HTA arrays and Illumina RNAseq for the analysis of tumours [RNA-seq] 1.23
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 1.23
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.22
Noncoding regions are the main source of targetable tumor-specific antigens 1.21
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 1.19
Next Generation Sequencing Facilitates Quantitative Analysis of Health donors and SLE patients' PBMC Transcriptomes 1.19
A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma 1.19
Leucegene: AML sequencing (part 6) 1.15
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 1.13
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.13
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 1.1
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.04
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 0.99
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.94
RNA-sequencing of human liver tissue 0.9
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 0.9
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 0.88
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 0.88
The transcriptome of Kawasaki Disease arteritis 0.86
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 0.84
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 0.84
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 0.84
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.8
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 0.79
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 0.79
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 0.79
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 0.78
Persistence of stem cell metabolism in cancers as a failure of differentiation 0.77
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.77
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.73
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.72
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.72
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.72
RNA-seq in endometrial stromal tumors 0.68
Leucegene: ALL sequencing 0.68
Neonatal and adult human testis defined at the single-cell level 0.68
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.68
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.68
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 0.67
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 0.66
Gene expression profile difference among renal location in a stone former 0.63
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 0.63
MYCL and EP400 are required for Max and MCPyV mediated gene activation 0.6
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.59
Transcriptome Profiling of Human Primary Monocytes 0.58
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 0.54
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 0.54
A single cell reference map for human blood and tissue T cell activation 0.54
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 0.53
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 0.52
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 0.52
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 0.51
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 0.51
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.51
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 0.5
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.5
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 0.5
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 0.5
RNA-seq of primary patient AML samples 0.47
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.46
Transcriptome analysis of CNS leukemia 0.45
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 0.45
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 0.45
Universal alternative splicing of noncoding exons 0.43
EP400 is required for Max and MCPyV mediated gene activation 0.43
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.43
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 0.42
LncRNA expression profiling of ischemic stroke patients 0.42
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.42
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 0.41
Gene expression of collecting duct carcinoma of the kidney 0.41
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 0.41
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 0.41
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 0.4
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.4
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.38
Hepatocyte maturation 0.38
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.37
RNA-Seq and expression data from human adipose tissue 0.37
RNA-sequencing 0.37
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 0.36
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.35
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.35
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.35
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 0.34
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 0.33
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 0.33
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 0.32
Primary Human B-cell Temporal Response to CD40L Stimulation 0.32
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.32
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.32
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 0.31
RNA-sequencing analysis of CD4 T cells following ipilimumab therapy 0.3
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.3
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.28
Transcriptomic analysis of frontal fibrosing alopecia 0.27
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 0.25
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.25
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.24
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.24
CUREfast: Accelerating research with families 0.24
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 0.23
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.23
Transcriptional changes during naturally-acquired ZIKA Virus infection render dendritic cells highly conducive to viral replication 0.23
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 0.22
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 0.21
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 0.21
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 0.2
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.2
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 0.2
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 0.2
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 0.19
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 0.18
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 0.18
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.18
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 0.18
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.18
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.18
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 0.18
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.17
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 0.17
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.17
Hierarchy of mono- and bi-allelic TP53 alterations in Multiple Myeloma cell fitness 0.16
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 0.16
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.16
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 0.16
An optimization system for isolating and sequencing of single human colon cancer cells 0.16
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 0.16
The Genomic Landscape of Atypical Fibroxanthoma 0.15
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 0.15
Improved LCL to iPSC reprogramming: RNA Analysis of LCLs, reprogrammed iPSCs, and differentiated NSCs reveal potential regulatory and functional processes involved in these cellular transitions. 0.15
Generation and functional characterization of MDSC-like cells 0.15
RNA-seq data from human lymphoma cell lines 0.15
ChIP-seq and RNA-seq from human lymphoma cell lines 0.15
Gene expression activation in CLL mediated by MSCs contact 0.15
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.15
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 0.15
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 0.14
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.14
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.14
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.14
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.13
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.13
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 0.13
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 0.13
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.13
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 0.12
HEK293 Heat-shock experiment 0.12
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.12
Transcriptome of human white and brown adipose tissue biopsies 0.12
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.12
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.11
Nonpregnant and term pregnant human myometrial tissues 0.11
Transcriptomic profiles of nonpregnant and term pregnant human myometrial tissues 0.11
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.11
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 0.11
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 0.1
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 0.1
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 0.1
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 0.1
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 0.1
Common inflammatory pathways between NEC and Crohn's disease 0.1
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 0.1
RNA-seq data 0.09
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 0.09
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 0.09
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 0.09
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 0.09
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.09
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 0.09
Defective structural RNA processing in relapsing-remitting multiple sclerosis 0.09
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 0.09
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 0.09
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.08
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 0.08
Clinker: visualizing fusion genes detected in RNA-seq data 0.08
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 0.08
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 0.08
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 0.08
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.08
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 0.08
Differential gene expressions in the heart of hypertrophic cardiomyopathy patients 0.08
Expression profiling of lncRNAs, miRNAs and mRNAs and their differential expression in leiomyoma using next generation RNA sequencing 0.08
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 0.08
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 0.08
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 0.07
Expression and functions of long noncoding RNAs during human T helper cell differentiation 0.07
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.07
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.07
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 0.07
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.07
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 0.06
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 0.06
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.06
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.06
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 0.06
KSDM1b Role in Ewing Sarcoma 0.06
Intron retention induced by microsatellite expansions as a disease biomarker. 0.06
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.06
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 0.06
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.06
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.05
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.05
Deep RNA sequencing of the human placental transcriptome 0.05
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 0.05
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 0.05
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 0.05
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 0.05
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.05
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 0.04
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.04
Gene expression profile of human placenta from T. Cruzi infected mothers 0.04
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 0.04
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.04
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 0.04
RNA-Seq of CD34+ Bone Marrow Progenitors from Healthy Donors 0.04
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 0.04
Identification of expressed and conserved human non-coding RNAs 0.03
RNA sequencing of T-ALL (COG study) 0.03
Analyses of T-ALL (COG study) 0.03
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.03
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.03
Identification of global regulators of T-helper cell lineage specification 0.03
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 0.03
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.03
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 0.03
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 0.03
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 0.03
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.02
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.02
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.02
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.02
RNA Seq of Alagille liver biopsies 0.02
Alagille_Nodder 0.02
Repurposing of promoters and enhancers during mammalian evolution 0.02
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 0.02
Gene expression analysis of human hepatocellular cancers 0.02
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.02
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.02
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 0.02
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 0.02
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 0.02
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 0.02
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.01
The human blood-nerve barrier transcriptome 0.01
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 0.01
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.01
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.01
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 0.01
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.01
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.01
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.01
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 0.01
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.01
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 0.01
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 0.0
Aging-associated patterns in the expression of human endogenous retroviruses 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation